Sedana Medical AB (SEDANA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sedana Medical AB (SEDANA) has a cash flow conversion efficiency ratio of -0.006x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-5.25 Million ≈ $-564.55K USD) by net assets (Skr900.78 Million ≈ $96.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sedana Medical AB - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Sedana Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Sedana Medical AB carry for a breakdown of total debt and financial obligations.
Sedana Medical AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sedana Medical AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Se Gyung Hi Tech Co.Ltd
KQ:148150
|
0.105x |
|
Nerdy Inc
NYSE:NRDY
|
-0.065x |
|
SAMYOUNG M-Tek Co. Ltd
KQ:054540
|
0.009x |
|
Nova Klúbburinn hf.
IC:NOVA
|
N/A |
|
Eusu Holdings
KO:000700
|
0.031x |
|
Merck Tbk
JK:MERK
|
0.165x |
|
Crossject
PA:ALCJ
|
2.893x |
|
Yuhwa Sec
KO:003460
|
0.183x |
Annual Cash Flow Conversion Efficiency for Sedana Medical AB (2016–2025)
The table below shows the annual cash flow conversion efficiency of Sedana Medical AB from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Sedana Medical AB market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr900.78 Million ≈ $96.94 Million |
Skr-12.78 Million ≈ $-1.38 Million |
-0.014x | -15.51% |
| 2024-12-31 | Skr958.23 Million ≈ $103.12 Million |
Skr-11.77 Million ≈ $-1.27 Million |
-0.012x | +68.70% |
| 2023-12-31 | Skr970.00 Million ≈ $104.39 Million |
Skr-38.06 Million ≈ $-4.10 Million |
-0.039x | +65.02% |
| 2022-12-31 | Skr1.03 Billion ≈ $110.75 Million |
Skr-115.43 Million ≈ $-12.42 Million |
-0.112x | -199.71% |
| 2021-12-31 | Skr1.10 Billion ≈ $118.53 Million |
Skr-41.22 Million ≈ $-4.44 Million |
-0.037x | -162.86% |
| 2020-12-31 | Skr551.09 Million ≈ $59.31 Million |
Skr-7.85 Million ≈ $-844.35K |
-0.014x | +6.83% |
| 2019-12-31 | Skr569.38 Million ≈ $61.27 Million |
Skr-8.70 Million ≈ $-936.28K |
-0.015x | +42.41% |
| 2018-12-31 | Skr217.81 Million ≈ $23.44 Million |
Skr-5.78 Million ≈ $-621.90K |
-0.027x | -723.16% |
| 2017-12-31 | Skr116.40 Million ≈ $12.53 Million |
Skr495.60K ≈ $53.33K |
0.004x | -97.74% |
| 2016-12-31 | Skr1.26 Million ≈ $135.81K |
Skr238.00K ≈ $25.61K |
0.189x | -- |
About Sedana Medical AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; S… Read more